Dow and Argonne will be collaborating on several new materials with the intent to improve the performance, cost competitiveness and adoption of these advanced materials in the energy storage industry.
Synthetic cells
Ion exchange leads to complex cell systems with inorganic membranes.
Hear live webcast tonight of top NJIT awardee detailing future of nanotechnology
Future of nanotechnology to detect viruses and more outlined.
Responsible development of nanotechnology
A new thesis by Ineke Malschat the Radboud University Nijmegen examines how ethically sound governance of nanotechnology may be possible in the current global world order.
Nanoinformatics 2011: Call for posters
Nanoinformatics 2011 will bring together informatics experts, nanotechnology researchers, and other stakeholders and potential contributors to advance Nanoinformatics 2020 Roadmap goals.
Nanosolar Achieves 17.1% Aperture Efficiency Through Printed CIGS Process
Thin film solar printing leader Nanosolar, Inc. today announced that the U.S. Department of Energy's National Renewable Energy Laboratory (NREL) has certified an aperture efficiency of 17.1% for a solar cell fabricated using Nanosolar's non-vacuum, low cost printing on flexible foil technology.
International nanoscience award for Irish scientist
Professor John Boland, Director of CRANN, the Science Foundation Ireland (SFI) funded nanoscience institute at Trinity College Dublin, has today been named the Laureate of the 2011 ACSIN Nanoscience Prize for his outstanding work in the development and application of scanning probe microscopy and spectroscopy and in the use of these tools to advance our understanding of chemical and physical phenomena of materials.
ARM and UMC Extend Long-Term IP Partnership into 28nm
ARM and UMC, a leading global semiconductor foundry, today announced a long-term agreement that provides UMC foundry customers with access to the latest advanced ARM Artisan Physical IP solutions validated on UMC's 28HPM process technology.
RUSNANO and I2BF Global Ventures Invest in Ultracapacitor Manufacturer Nesscap Energy
Proceeds from this financing will be used as to approximately $15,000,000 for the establishment of a full scale production facility for ultracapacitors and fundamental research center in the Russian Federation and as to approximately $5,000,000 for the expansion of Nesscap's current manufacturing and core R+D operations in Korea and for general corporate purposes.
Call for papers for the Journal of Nanoengineering and Nanosystems
You are invited to submit your latest research for publication in the Journal of Nanoengineering and Nanosystems.
Sodium Bicarbonate In The Prevention and Reversal of All Dis-Ease
Over the last decade Dr. Ralph Moss, at the University of Arizona has been researching the use of sodium bicarbonate (NaHCO3) as a potential treatment for cancerous conditions.
At the same time Robert J. Gillies and his colleagues have demonstrated that pre-treatment of mice with sodium bicarbonate results in the alkalinization of the area around tumors. (Raghunand 2003)
Using sodium bicarbonate in the treatment of a cancerous condition has been found to "enhance the anti-tumor activity" of other anticancer drugs. The alkalizing effects are very similar to the recently published research of injecting O2 directly into tumors where such direct administration of oxygen also facilitated the action of chemotherapy.
This year the same researchers reported that sodium bicarbonate increases tumor pH (i.e., make it more alkaline) and also inhibits spontaneous metastases (Robey 2009). They also showed that oral sodium bicarbonate increased the pH of tumors and also reduced the formation of spontaneous metastases in mice with breast cancer. Oral administration of sodium bicarbonate also reduced the rate of lymph node involvement. Read more...
Source:
http://anti-aging-for-today.blogspot.com/feeds/posts/default?alt=rss
Physical Therapy Gym Tech
Physical Therapy Gym Tech
To: Future Health Professionals
From: Kyle Kacerek
Re: Job opening
Are you a graduate or graduating senior? Are you thinking about applying to a grad school in a health-related field? Would you like to get some real clinical experience? If so, then Tygiel Physical Therapy is the place for you! We are looking for majors in physiology or related fields.
A position will be opening at Tygiel Physical Therapy as a gym tech. The position will begin training ASAP, and no prior training is required. If you are still in school, arrangements can be made to work around your school schedule. The position is part-time, but full-time employment will be considered if the right candidate requests it.
The position involves instructing patients in therapeutic exercises under the guidance of a physical therapist. You will also be trained in the various treatment modalities such as ultrasound and electrical stimulation.
I am a UA Physiology alumni and would recommend this position to anyone who has health care ambitions, especially if you are considering Physical Therapy as a future profession. We are located down the street from St. Joseph's hospital.
If you are interested, please come by to fill out an application:
6606 E. Carondelet Dr.
Tucson, AZ 85710
Source:
http://physiologynews.blogspot.com/feeds/posts/default?alt=rss
Muralcles Meeting
Muralcles 2nd General Meeting:
Wednesday, October 5th, from 5p.m.-6p.m.
Sabino Room, 3rd Floor of Student Union.
We will be having event sign-ups and decorating art bags for our pediatric patients!
New members are always welcome!
For New Members:
1. Join Orgsync.com by clicking: https://orgsync.com/3077/chapter.
2. Make an Orgsync account and request to join the Muralcles Orgsync page. You don't need a password, just request to join the organization.
3. Read the Welcome message on Orgsync and fill out the New Membership form.
4. Accumulate 5 points throughout the semester (Meetings = 1 point, Events = 2 points, Other Events = 2 points) to gain Active Membership status.
Shirts:
Unfortunately there are only medium and large shirts left, which will be available for pick-up and for buy at this meeting. Some people have already emailed me about shirt pick up so these have been reserved for you!
Unable to make the meeting?
That's okay! We will email you a meeting recap and events will open up on Orgsync for RSVPing.
Email questions to tucsonmuralcles@gmail.com.
To Remove Yourself from this List Send a message to listserv@listserv.arizona.edu with the message: SIGNOFF Muralcles.
Source:
http://physiologynews.blogspot.com/feeds/posts/default?alt=rss
Whole Body Vibration Research Study
Curious about how to improve your flexibility?
Find out by participating in our research study!
We are currently looking for healthy male and female participants aged 18-30 years old to participate in a study that will assess the effect of whole body vibration on muscle flexibility range of motion.
You need to be:
Healthy with no history of lower back pain and no history of cardiovascular disorders, migraines, epilepsy.
For this study, you will be randomized into 3 groups: Control Group, Treadmill Group, Whole Body Vibration Group. You will come to the Gittings Building at the University of Arizona every other day (three times a week) for a period of 2 weeks. Each session will last 15-30 minutes and consist of performing a sit and reach test followed by 5 minutes of activity (or 5 minutes of no activity if you are in control group) and then a follow-up sit and reach test. During the first visit, your body height and weight will be measured.
There is no cost to you to participate in this study. At any time (even after you give permission), you may refuse to perform a particular activity or drop from the study altogether. This is 100% okay with us; it is your decision to make and it will not affect your participation in any other activities at the University of Arizona.
Interested? Please contact richtera@email.arizona.edu or (480) 203-0645 for more information!
Source:
http://physiologynews.blogspot.com/feeds/posts/default?alt=rss
Panel recommends no more PSA test as a screening tool
Wonder how the laboratory and urology community will do with this information:
U.S. Panel Says No to Prostate Screening for Healthy Men
Apparently the serum test as well as the rectal exam and ultrasound are not effective either. This is for healthy men without symptoms only. Not sure what the effective screening tool is then because you screen healthy, not ill individuals. Certain to be a lot of pushback, fighting, action groups, political battles and contradictory data to this new recommendation. Stay tuned.
Source:Dark Daily visits the anatomic pathology department and clinical laboratory at University Health Network
Dark Daily editor Robert Michel writes about the successes of digital pathology in Ontario from a recent visit.
DATELINE: Toronto, Ontario, Canada—Here in the downtown area of Ontario’s largest city is a healthcare organization known as University Health Network (UHN) that operates one of the province’s larger consolidated clinical laboratory organizations. In support of its hospitals, the UHN Laboratory provides an impressive menu of medical laboratory tests.
Read entire story.
Source:Open Source Digital Pathology Consortium Announced
Pittsburgh, Pennsylvania, USA - October 6, 2011
The Open Source Digital Pathology Consortium, Inc. (“OpenDP”) announced its formation today at the Pathology Informatics 2011 meeting in Pittsburgh, PA. The Consortium shall be known as OpenDP.
OpenDP engages academic medical centers, research institutions, and digital pathology manufacturers to create an open source community. The community will contribute and build open source tools for digital pathology. Much of this code has been funded by federal grants and universities. These tools are open to all to use freely.
To date founding members have contributed over 70 person years of effort to open source code for the benefit of the OpenDP community. OpenDP plans to represent our community’s interests as it relates to digital pathology standards.
“With the increased digital pathology adoption at academic medical centers and research institutions,” stated Mahadev Satyanarayanan (Satya), founding Technical Director of OpenDP, “the evolution of an open source community is vital for digital pathology innovation.” Satya is the Carnegie Group Professor of Computer Science at Carnegie Mellon University, and serves as Technical Director to provide leadership for the consortium’s mission.
The founding members include:
- Queens University
- Robert Wood Johnson Medical School, UMDNJ, Center for Biomedical Imaging & Informatics
- The Research Institute at Nationwide Children's Hospital
- Yale University School of Medicine, Pathology Informatics
- Mass General Hospital, Pathology Imaging and Communication Technology Center
- University of Kansas Medical Center
- University of South Florida
- Johns Hopkins University
- Emory University, Center for Comprehensive Informatics
- Keck School of Medicine University of Southern California at Children’s Hospital Los Angeles
- University of Michigan Health System, Division of Pathology Informatics
- The University of Texas MD Anderson Cancer Center
- Carnegie Mellon University
Please check http://www.opendp.org to participate and sponsor the community’s growth.
Source:Steve Jobs — How to live before you die
Source:Check out Leica Science Lab – the Knowledge Portal for Microscopy and Histology
Wetzlar, Germany. Leica Science Lab (http://www.leica-microsystems.com/science-lab), the knowledge portal of Leica Microsystems, offers scientific research and teaching material on the subjects of microscopy and histology, from the basics to specific application know-how.
Learn. Share. Contribute.
Illustrated and interactive tutorials as well as white papers explain technical rudiments all the way from specimen preparation and immunochemistry to imaging, contrast techniques and high-end technologies such as super-resolution. In addition, Leica Science Lab features scientific articles on special techniques, applications and areas of research. The content is designed to support beginners, experienced practitioners and scientists alike in their everyday work and experiments. What’s more, the range of topics offered by the portal will be continuously widened.
Leica Science Lab invites its readers to discuss the articles and topics presented. Users’ comments and questions will be used to improve the information on an ongoing basis. At the time of the official go-live date, 100 authors had contributed to filling the portal with in-depth content. Experts in science, methods, and techniques who would like to share their knowledge with the community are cordially invited to publish their articles in Leica Science Lab.
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.
Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.
Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.
The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.
Source:Superiority of virtual microscopy versus light microscopy in transplantation pathology
Nice study in this month's Clinical Transplantation on light versus virtual microscopy.
Increasingly studies are showing equal or superior interobserver agreement with virtual over light microscopy.
What if we find whole slides are better than glass slides in terms of diagnostic accuracy compared with "truth" or "gold standard" diagnosis?
Clin Transplant. 2011 Sep 29. doi: 10.1111/j.1399-0012.2011.01506.x. [Epub ahead of print]
Ozluk Y, Blanco PL, Mengel M, Solez K, Halloran PF, Sis B.
Source
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey Alberta Transplant Applied Genomics Centre Department of Medicine, Division of Nephrology and Transplant Immunology, University of Alberta, Edmonton, AB, Canada.
Abstract
Virtual microscopy has begun to change conventional pathology practice. We tested the reliability of this new technology in transplantation pathology. We studied 40 kidney transplant biopsies for cause and compared reproducibility of Banff scores using virtual slides versus glass slides. Three glass slides per biopsy were scanned as high-resolution digital slides using Aperio ScanScope. Three pathologists independently reviewed the biopsies: twice by glass slides and twice by virtual slides. Eleven histopathological lesions were scored and used to construct diagnosis according to Banff criteria. The intra-observer reproducibility of Banff scores was substantially good using either virtual slides or glass slides (mean ?: 0.69 vs. 0.64, p?>?0.05). The inter-observer reproducibility of Banff scores was better in virtual slides than in glass slides (mean ?: 0.42 vs. 0.28, p?<?0.001). Among the lesions, transplant glomerulopathy scoring by virtual slides showed the highest inter-observer reproducibility, with a similar accuracy to glass slides. The agreement for acute rejection between virtual and glass slides was not different from the agreement between two readings of glass slides. Thus, virtual microscopy is a reliable and more reproducible technology and has several advantages over glass slides, e.g., accessibility via internet, no fading. We recommend virtual microscopy for transplant diagnostics, including utilization for clinical trials.
Source: